BackRevive Therapeutics Overview
Revive Therapeutics Ltd.

Revive Therapeutics Return on Equity

Latest ROE for Revive Therapeutics: 25.48% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

25.48%

Return on Equity

25.48%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Revive Therapeutics (RVVTF) FAQ

As of the most recent data, RVVTF shows a ROE of 25.48%. That is above the sector sector average of 10.27%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 10.27%. Revive Therapeutics is at 25.48%, which is higher that average. That is roughly 148.2% above the sector mean. Use the comparison chart on this page to see how RVVTF stacks up against individual peers as well.

Check the historical chart to see whether RVVTF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Revive Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Revive Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 25.48%) with ownership activity and broader fundamentals.

Questions & Answers